Biotherapeutics
Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial. In one of the largest studies of cell intervention after a heart attack, patients reported their daily hardship lessened when stem cells optimized for heart repair supplemented standard of care. This clinical study further documented lower death and hospitalization rates among those treated with cell therapy. This research is published in Stem Cells Translational Medicine.
Latest stories
Research
April 1, 2024
Neurosciences
April 1, 2024
AI and Digital Health
March 29, 2024
Individualized Medicine
March 20, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community